NASDAQ$MURA

Mural Oncology Plc · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Headline financials

EPS (adj)

-$8.46

No prior period
Capital Expenditures

$5.37M

No prior period
Free Cash Flow

-$136M

No prior period
Net Income

-$50.6M

No prior period
Operating Income

-$49.3M

No prior period
Stock-Based Comp

$8.73M

No prior period

Revenue & EPS history

Mural Oncology · Revenue · Quarterly

-$1

Q3 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 7 quarterly earnings reports

Historical avg

-9.3%

Avg return

Earnings day

-9.4%

Avg return

5 days after

+5.1%

Avg return

30 days after

23%

3 / 13 earnings

Positive

+14.6%

Q4 2023

Best reaction

-61.6%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025
Q3 2025-0.5%-0.5%
Q2 2025-20.2%-30.3%-9.2%
Q1 2025-4.4%-4.7%-10.9%
Q4 2024-61.6%-65.0%-31.3%
Q3 2024-0.9%-4.8%+2.3%
Q2 2024+1.0%+4.5%+0.6%
Q1 2024+2.7%+4.0%-12.0%
Q4 2023+14.6%+13.2%-16.7%
Q1 2023-10.4%-7.7%+27.7%
Q2 2023-10.4%-7.7%+27.7%
Q3 2022-10.4%-7.7%+27.7%
Q4 2022-10.4%-7.7%+27.7%
Q3 2023-10.4%-7.7%+27.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro